PMC 2809139
In practice, exogenous follistatin delivery is not currently clinically feasible the molecule doesn't survive oral administration, injectable forms have short half-lives, and there is no approved delivery system
The internalization pathway depends on the characteristics of the nanoparticle as it also defines in which part of the cell or organelle the nanoparticle will end up
Other factors that may increase your chances for gout include: Being male Being obese Having certain health conditions like: Congestive heart failure Hypertension (high blood pressure) Insulin resistance Metabolic syndrome Diabetes Drinking alcohol
the present invention furthermore relates to a BPC peptide salt or a pharmaceutical or diagnostic composition according to the above wherein the general formula (II) is the present invention relates in particular to a BPC peptide salt or a pharmaceutical or diagnostic composition a BPC peptide salt or a pharmaceutical or diagnostic composition comprising a salt of a BPC peptide according to the above general formula (I) wherein the peptide is selected from the group consisting of: the peptides may be linked to other functional and/or structural moieties such as carbohydrates, fats, proteins or peptides, antibodies, receptors, hormones, cytotoxic substances, marker substances, dyes, radioactive labels, immunomodulatory agents, drugs, carriers, targeting or signalling substances, etc
Preclinical trials conducted on rats demonstrate measurable improvements in transected tendon reattachment and Achilles tendon rupture models, though human clinical data remain limited
